Oncolytics Biotech, Inc. (ONCY)
0.7519
-0.02
(-2.60%)
USD |
NASDAQ |
Sep 11, 16:00
0.7519
0.00 (0.00%)
After-Hours: 16:29
Oncolytics Biotech Gross Profit (TTM) : -0.11M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.11M |
| March 31, 2026 | -0.113M |
| December 31, 2025 | -0.1646M |
| September 30, 2025 | -0.1646M |
| June 30, 2025 | -0.1576M |
| March 31, 2025 | -0.1606M |
| December 31, 2024 | -0.113M |
| September 30, 2024 | -0.1916M |
| June 30, 2024 | -0.1964M |
| March 31, 2024 | -0.2468M |
| December 31, 2023 | -0.2985M |
| September 30, 2023 | -0.2929M |
| June 30, 2023 | -0.291M |
| March 31, 2023 | -0.296M |
| December 31, 2022 | -0.3013M |
| September 30, 2022 | -0.3053M |
| June 30, 2022 | -0.2975M |
| March 31, 2022 | -0.3545M |
| December 31, 2021 | -0.3617M |
| September 30, 2021 | -0.3674M |
| June 30, 2021 | -0.3827M |
| March 31, 2021 | -0.3321M |
| December 31, 2020 | -0.3326M |
| September 30, 2020 | -0.3372M |
| June 30, 2020 | -0.342M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3461M |
| December 31, 2019 | -0.3659M |
| September 30, 2019 | -0.2996M |
| June 30, 2019 | -0.2329M |
| March 31, 2019 | -0.1624M |
| December 31, 2018 | -0.0735M |
| September 30, 2018 | -0.0686M |
| June 30, 2018 | -0.0646M |
| March 31, 2018 | -0.0673M |
| December 31, 2017 | -0.0698M |
| September 30, 2017 | -0.0744M |
| June 30, 2017 | -0.0917M |
| March 31, 2017 | -0.1072M |
| December 31, 2016 | -0.1225M |
| September 30, 2016 | -0.136M |
| June 30, 2016 | -0.1365M |
| March 31, 2016 | -0.1383M |
| December 31, 2015 | -0.1413M |
| September 30, 2015 | -0.1471M |
| June 30, 2015 | -0.1495M |
| March 31, 2015 | -0.1483M |
| December 31, 2014 | -0.1479M |
| September 30, 2014 | -0.1463M |
| June 30, 2014 | -0.1493M |
| March 31, 2014 | -0.139M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.117B |
| Anixa Biosciences, Inc. | -0.039M |
| Vicapsys Life Sciences, Inc. | 0.00 |